Sherry is a member of the firm’s chemical and biotechnology patent practice group, counseling clients on the procurement of patent protection in the U.S. and internationally, and assisting in freedom to operate and due diligence review for their innovations. She has extensive experience with a variety of inventions, including small molecule pharmaceuticals, polymers, personalized medicine, tissue engineering, drug delivery systems and medical devices, as well as worldwide prosecution experience.
Sherry earned her B.A. in neuroscience, with a focus on molecular biology, chemistry and mathematics, magna cum laude, from Oberlin College, and her J.D., cum laude, from the University of San Francisco, with CALI awards in patent law and international intellectual property. During law school, she served as a comments editor on the law review editorial board and worked as a patent agent in San Jose, California.
Prior to her legal career, Sherry worked as a research technologist in laboratories at Northwestern University and the Stanford University Medical Center, and has co-authored publications in scientific journals. Her research at Northwestern involved the biophysics of protein import into mitochondria. While at Stanford, she studied the sodium bicarbonate transporters and their role in regulating pH in brain tissues.
Sherry is a member of the North Carolina bar and is registered to practice before the U.S. Patent and Trademark Office. She is an active member of the AIPLA biotechnology group and is past president of the Carolina Patent Trademark and Copyright Law Association (CPTCLA).
“Due Diligence and Licensing of Intellectual Property Overview, Recent Developments and Practice Tips” Association of Corporate Counsel, May 2016
“Life After Myriad: The U.S. Supreme Court Restricts Patentable Subject Matter” Myers Bigel Sibley & Sajovec Lunch CLE, August 2013
“Patenting in the Age of Crowdsourcing: An Expanded Opportunity for Third Party Participation” LawReview CLE, April 2013[/vc_column_text][/vc_column][/vc_row]